Literature DB >> 2465297

Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.

K C Flanders1, N L Thompson, D S Cissel, E Van Obberghen-Schilling, C C Baker, M E Kass, L R Ellingsworth, A B Roberts, M B Sporn.   

Abstract

We have localized transforming growth factor-beta (TGF-beta) in many cells and tissues with immunohistochemical methods, using two polyclonal antisera raised to different synthetic preparations of a peptide corresponding to the amino-terminal 30 amino acids of TGF-beta 1. These two antibodies give distinct staining patterns; the staining by anti-CC(1-30) is intracellular. This differential staining pattern is consistently observed in several systems, including cultured tumor cells; mouse embryonic, neonatal, and adult tissues; bovine fibropapillomas; and human colon carcinomas. The extracellular staining by anti-CC(1-30) partially resembles that seen with an antibody to fibronectin, suggesting that extracellular TGF-beta may be bound to matrix proteins. The intracellular staining by anti-LC(1-30) is similar to that seen with two other antibodies raised to peptides corresponding to either amino acids 266-278 of the TGF-beta 1 precursor sequence or to amino acids 50-75 of mature TGF-beta 1, suggesting that anti-LC(1-30) stains sites of TGF-beta synthesis. Results from RIA and ELISAs indicate that anti-LC(1-30) and anti-CC(1-30) recognize different epitopes of this peptide and of TGF-beta 1 itself.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465297      PMCID: PMC2115454          DOI: 10.1083/jcb.108.2.653

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  22 in total

1.  Identification of another member of the transforming growth factor type beta gene family.

Authors:  P ten Dijke; P Hansen; K K Iwata; C Pieler; J G Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

2.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.

Authors:  K Miyazono; U Hellman; C Wernstedt; C H Heldin
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

3.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.

Authors:  L M Wakefield; D M Smith; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

4.  Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells.

Authors:  J R Florini; A B Roberts; D Z Ewton; S L Falen; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

5.  Developmental expression of transforming growth factors alpha and beta in mouse fetus.

Authors:  J N Wilcox; R Derynck
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

6.  Antibodies to peptide determinants in transforming growth factor beta and their applications.

Authors:  K C Flanders; A B Roberts; N Ling; B E Fleurdelys; M B Sporn
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

Review 7.  Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors:  M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

8.  Role of transforming growth factor-beta in the development of the mouse embryo.

Authors:  U Heine; E F Munoz; K C Flanders; L R Ellingsworth; H Y Lam; N L Thompson; A B Roberts; M B Sporn
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

9.  Peptides as antigens. Importance of orientation.

Authors:  T Dyrberg; M B Oldstone
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones.

Authors:  M Sandberg; T Vuorio; H Hirvonen; K Alitalo; E Vuorio
Journal:  Development       Date:  1988-03       Impact factor: 6.868

View more
  95 in total

1.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis.

Authors:  B K Hall; T Miyake
Journal:  Anat Embryol (Berl)       Date:  1992-07

3.  Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta.

Authors:  J J Letterio; T Lehrnbecher; G Pollack; T J Walsh; S J Chanock
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

Authors:  E P Böttinger; V M Factor; M L Tsang; J A Weatherbee; J B Kopp; S W Qian; L M Wakefield; A B Roberts; S S Thorgeirsson; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Authors:  Y Miyazaki; K Araki; C Vesin; I Garcia; Y Kapanci; J A Whitsett; P F Piguet; P Vassalli
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

8.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Authors:  M E Kadin; B A Agnarsson; L R Ellingsworth; S R Newcom
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

10.  L-arginine may mediate the therapeutic effects of low protein diets.

Authors:  I Narita; W A Border; M Ketteler; E Ruoslahti; N A Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.